ArticleNeuroImage2017
Regional and source-based patterns of [
Registry-linked trialAbstract read
In one paragraph
Article in NeuroImage, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05105542 (Muscarinic M1 Receptor Availability and Cognition in Schizophrenia), which is not on this map. Cited by 29 papers.
0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Muscarinic M1 Receptor Availability and Cognition in Schizophrenia
Who cites it
29 citing papers in PubMed, 43 citations in OpenAlex.
- Longitudinal changes in network engagement during cognitive control in cocaine use disorder.Drug and alcohol dependence · 2021Trial
- Multiple sources of β2*-nicotinic acetylcholine receptor binding are differentially affected during tobacco smoking abstinence as revealed by Independent Component Analysis of [Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026Article
- Molecular connectivity studies in neurotransmission: a scoping review.Imaging neuroscience (Cambridge, Mass.) · 2025Article
- Higher levels of D2R and D3R in the frontal-striatal regions are associated with reduced perseverative reward seeking after opioid abstinence.Frontiers in behavioral neuroscience · 2025Article
- Involvement of dopamine D3 receptor in impulsive choice decision-making in male rats.Neuropharmacology · 2024Article
- A shared spatial topography links the functional connectome correlates of cocaine use disorder and dopamine DCommunications biology · 2024Article
- Are There Prevalent Sex Differences in Psychostimulant Use Disorder? A Focus on the Potential Therapeutic Efficacy of Atypical Dopamine Uptake Inhibitors.Molecules (Basel, Switzerland) · 2023Review
- Sex/Gender Differences in the Time-Course for the Development of Substance Use Disorder: A Focus on the Telescoping Effect.Pharmacological reviews · 2023Review
- Effects of chronic cocaine and ethanol self-administration on brain dopamine receptors in a rhesus monkey model of polysubstance abuse.Addiction biology · 2022Article
- Multimodal neuroimaging of metabotropic glutamate 5 receptors and functional connectivity in alcohol use disorder.Alcoholism, clinical and experimental research · 2022Article
- Relationships between dopamine D2/3 receptor availability and social-environmental factors in humans.Neuroscience letters · 2022Article
- Dopamine dysfunction in stimulant use disorders: mechanistic comparisons and implications for treatment.Molecular psychiatry · 2022Review
- Data-driven analysis of kappa opioid receptor binding in major depressive disorder measured by positron emission tomography.Translational psychiatry · 2021Article
- Identifying brain networks in synaptic density PET (NeuroImage · 2021Article
- Dopamine 'ups and downs' in addiction revisited.Trends in neurosciences · 2021Review
- Dopamine DDrug and alcohol dependence · 2021Article
- Multimodal investigation of dopamine DNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021Article
- Association of dopamine DNeuroImage · 2020Article
- Dysregulation of Decision Making Related to Metabotropic Glutamate 5, but Not Midbrain DBiological psychiatry · 2020Article
- Evidence for Dopamine Abnormalities in the Substantia Nigra in Cocaine Addiction Revealed by Neuromelanin-Sensitive MRI.The American journal of psychiatry · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Patrick D WorhunskyDepartment of Radiology & Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA. Electronic address: patrick.worhunsky@yale.edu.
David MatuskeyDepartment of Radiology & Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Jean-Dominique GallezotDepartment of Radiology & Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
Edward C GaiserDepartment of Radiology & Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Nabeel NabulsiDepartment of Radiology & Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
Gustavo A AngaritaDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Vince D CalhounDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA; Department of Electrical & Computer Engineering, University of New Mexico, Albuquerque, NM, USA; The Mind Research Network, Albuquerque, NM, USA.
Robert T MalisonDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Marc N PotenzaDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA; Child Study Center, Yale School of Medicine, New Haven, CT, USA; Department of Neuroscience, Yale School of Medicine, New Haven, CT, USA; National Center on Addiction and Substance Abuse, Yale School of Medicine, New Haven, CT, USA.
Richard E CarsonDepartment of Radiology & Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
Yale University · USUniversity of New Mexico · US
Funding
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9MYale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8MSUBSTANCE ABUSEK12DA000167 · NIDA · YALE UNIVERSITY · PI STEPHANIE S O'MALLEY, Marc N Potenza · 1991 to 2026
$17.7MTranscranial Direct Current Stimulation for Treatment of Auditory Verbal HalluciP20GM103472 · NIGMS · THE MIND RESEARCH NETWORK · PI THOMA, ROBERT J · 2012 to 2017
$14.3MMultivariate methods for identifying multitask/multimodal brain imaging biomarkersR01EB006841 · NIBIB · THE MIND RESEARCH NETWORK · PI VINCE D CALHOUN, Sergey Plis · 2007 to 2026
$9.8MNeuroimaging Sciences Training ProgramT32DA022975 · NIDA · YALE UNIVERSITY · PI Graeme F Mason, Rajita Sinha · 2007 to 2026
$5.7MInformed Data-Driven Fusion of Behavior, Brain Function, and GenesR01EB005846 · NIBIB · THE MIND RESEARCH NETWORK · PI CALHOUN, VINCE D · 2005 to 2016
$5.5MTranslational Research of Cocaine, Striatum, and ImpulsivitiesP20DA027844 · NIDA · YALE UNIVERSITY · PI POTENZA, MARC N · 2010 to 2013
$3.6MUnified multivariate data-driven solutions for static and dynamic brain connectivityR01EB020407 · NIBIB · THE MIND RESEARCH NETWORK · PI ADALI, TULAY, CALHOUN, VINCE D · 2015 to 2018
$2.7MFunctional networks related to cocaine dependence and its treatment and relapseR01DA039136 · NIDA · YALE UNIVERSITY · PI POTENZA, MARC N · 2016 to 2018
$754kDBH, D2High and Cocaine Paranoia/Aversion: A [11C]PHNO PET StudyR03DA027456 · NIDA · YALE UNIVERSITY · PI MALISON, ROBERT T · 2009 to 2010
$420kNCATS NIH HHS UL1 TR000142NCATS NIH HHS UL1 TR001863NIBIB NIH HHS R01 EB005846NIBIB NIH HHS R01 EB006841NIBIB NIH HHS R01 EB020407NIDA NIH HHS K12 DA000167NIDA NIH HHS P20 DA027844NIDA NIH HHS R01 DA039136NIDA NIH HHS R03 DA027456NIDA NIH HHS T32 DA022975NIGMS NIH HHS P20 GM103472
Abstract
Dopamine type 2 and type 3 receptors (D
Indexed as
AdultBrainBrain MappingCocaine-Related DisordersDisease ProgressionDopamine AgentsFemaleHumansImage Processing, Computer-AssistedMaleMiddle AgedOxazinesPositron-Emission TomographyRadiopharmaceuticalsReceptors, Dopamine D2Receptors, Dopamine D3Dopamine AgentsDRD2 protein, humanDRD3 protein, humannaxagolideOxazinesRadiopharmaceuticalsReceptors, Dopamine D2Receptors, Dopamine D3[(11)C]-(+)-PHNOAddictionCocaine use disorderDopamineIndependent component analysisStriatum
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
NCT05105542ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.